Dr Callander on Early CAR T-cell Therapy Referrals in Multiple Myeloma

Natalie S. Callander, MD, discusses the potential benefits of referring patients with multiple myeloma to CAR T-cell therapy earlier in their disease course.

Related Keywords

Wisconsin ,United States ,University Of Wisconsin ,Natalies Callander , ,University Of Wisconsin School Medicine ,Public Health ,Division Of Hematology ,Department Of Medicine ,Medical Oncology ,Palliative Care ,Wisconsin School ,D ,University Of Wisconsin School Medicine And Public Health ,University Of Wisconsin Carbone Cancer Center ,Patients With Multiple Myeloma ,Karmma Trial ,Nct03361748 ,Cartitude 1 Trial ,Nct03548207 ,Cartitude 4 Trial ,Nct04181827 ,Karmma 3 Trial ,Nct03651128 ,